Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Hyperparathyroidism-Chronic Kidney Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00316472
What this trial is testing

The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients

Who this might be right for
Hyperphosphatemia
Washington University School of Medicine 40
Not applicableUnknownNCT02464072
What this trial is testing

Subtotal Parathyroidectomy or Total Parathyroidectomy With Autograft in Chronic Kidney Disease Patients Under Dialysis

Who this might be right for
Hyperparathyroidism, Secondary
University of Sao Paulo General Hospital 133
Post-approval studies (Phase 4)Study completedNCT00958451
What this trial is testing

Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
Salem Veterans Affairs Medical Center 80
Post-approval studies (Phase 4)Study completedNCT00257920
What this trial is testing

Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease, Stage 5Secondary Hyperparathyroidism
Abbott 41
Post-approval studies (Phase 4)Study completedNCT00053547
What this trial is testing

Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on Hemodialysis

Who this might be right for
Secondary HyperparathyroidismEnd Stage Renal Disease
Abbott 28
Not applicableStudy completedNCT00999037
What this trial is testing

FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease

Who this might be right for
Secondary Hyperparathyroidism
University of California, Los Angeles 18
Not applicableLooking for participantsNCT07312981
What this trial is testing

The CPH-MBD Cohort Dietary Substudy - Comparison of Methods for Dietary Registrations

Who this might be right for
CKDRenal Insufficiency ChronicCKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder+1 more
University of Copenhagen 50
Large-scale testing (Phase 3)Study completedNCT01788046
What this trial is testing

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 515
Not applicableUnknownNCT03082742
What this trial is testing

The Effect of Diuretics on Mineral and Bone Disorder in Chronic Kidney Disease Patients

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
University of Sao Paulo General Hospital 52
Large-scale testing (Phase 3)Ended earlyNCT01012414
What this trial is testing

Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease

Who this might be right for
Coronary Artery DiseaseChronic Kidney DiseaseHypovitaminosis D+1 more
Thomas Jefferson University 10
Large-scale testing (Phase 3)Study completedNCT01071070
What this trial is testing

Evaluate Safety and Efficacy of Paricalcitol in Reducing Serum Intact Parathyroid Hormone in Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Abbott 216
Post-approval studies (Phase 4)Study completedNCT00977080
What this trial is testing

Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D

Who this might be right for
Chronic Kidney DiseaseSecondary HyperparathyroidismHemodialysis
Abbott 272
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07654231
What this trial is testing

Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKD

Who this might be right for
Chronic Kidney Disease Mineral and Bone DisorderHypertensionDiabetes+3 more
University of Texas Southwestern Medical Center 60
Large-scale testing (Phase 3)Study completedNCT05832931
What this trial is testing

Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-1

Who this might be right for
Secondary HyperparathyroidismEnd-stage Kidney Disease (ESKD)
Pathalys Pharma 362
Large-scale testing (Phase 3)Looking for participantsNCT07122401
What this trial is testing

Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism

Who this might be right for
Secondary Hyperparathyroidism, Chronic Kidney Disease
Shaanxi Micot Pharmaceutical Technology Co., Ltd. 424
Testing effectiveness (Phase 2)WithdrawnNCT01665651
What this trial is testing

Kidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy

Who this might be right for
Renal Insufficiency, ChronicRenal Osteodystrophy
Bing Shu
Large-scale testing (Phase 3)Study completedNCT00037635
What this trial is testing

An Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients

Who this might be right for
Secondary HyperparathyroidismEnd Stage Renal Disease
Amgen 400
Post-approval studies (Phase 4)Study completedNCT00379899
What this trial is testing

ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis

Who this might be right for
Chronic Kidney DiseaseEnd Stage Renal DiseaseCoronary Artery Calcification+8 more
Amgen 360
Not applicableStudy completedNCT04674397
What this trial is testing

BOne Dysfunction in Donor NEphrectomieS

Who this might be right for
Renal FailureKidney Donors
Manchester University NHS Foundation Trust 34
Not applicableStudy completedNCT01149291
What this trial is testing

Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Who this might be right for
Secondary HyperparathyroidismEnd Stage Renal Disease
AbbVie (prior sponsor, Abbott) 511
Next Page